Drug targets hard-to-reach leukemia stem cells responsible for relapses: The findings, published in the January 17 online issue of Cell Stem Cell, open the possibility that diseases like chronic myeloid leukemia (CML) and some solid tumor cancers might – in combination with other therapies – be more effectively treated with ...
See all stories on this topic » Get current organ donation and transplantation information : www.transplantviews.blogspot.com
Home
»
»Unlabelled
» Drug targets hard-to-reach leukemia stem cells responsible for relapses
Thursday, 17 January 2013
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment